Compounds > 9-(2',3'-dihydroxycyclopent-4'-enyl)adenine
Page last updated: 2024-10-21

9-(2',3'-dihydroxycyclopent-4'-enyl)adenine and Anasarca

9-(2',3'-dihydroxycyclopent-4'-enyl)adenine has been researched along with Anasarca in 1 studies

9-(2',3'-dihydroxycyclopent-4'-enyl)adenine: structure given in first source; S-adenosyl homocysteine hydrolase antagonist

Research Excerpts

ExcerptRelevanceReference
" In rat peptidoglycan polysaccharide-induced arthritis, orally dosed DHCaA significantly suppressed inflamed paw volumes with minimal effective dose of 0."1.31S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis. ( Conner, EM; Saso, Y; Teegarden, BR; Yuan, CS, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saso, Y1
Conner, EM1
Teegarden, BR1
Yuan, CS1

Other Studies

1 other study available for 9-(2',3'-dihydroxycyclopent-4'-enyl)adenine and Anasarca

ArticleYear
S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis.
    The Journal of pharmacology and experimental therapeutics, 2001, Volume: 296, Issue:1

    Topics: Adenosine; Adenosylhomocysteinase; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Expe

2001